Documents
Application Sponsors
ANDA 208454 | SUN PHARM INDS LTD | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET; ORAL | 2.5MG/500MG | 0 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
002 | TABLET; ORAL | 2.5MG/850MG | 0 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
003 | TABLET; ORAL | 2.5MG/1GM | 0 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2020-05-28 | STANDARD |
Submissions Property Types
CDER Filings
SUN PHARM INDS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 208454
[companyName] => SUN PHARM INDS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"LINAGLIPTIN AND METFORMIN HYDROCHLORIDE","activeIngredients":"LINAGLIPTIN AND METFORMIN HYDROCHLORIDE","strength":"2.5MG\/500MG","dosageForm":"TABLET; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"LINAGLIPTIN AND METFORMIN HYDROCHLORIDE","activeIngredients":"LINAGLIPTIN AND METFORMIN HYDROCHLORIDE","strength":"2.5MG\/850MG","dosageForm":"TABLET; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"LINAGLIPTIN AND METFORMIN HYDROCHLORIDE","activeIngredients":"LINAGLIPTIN AND METFORMIN HYDROCHLORIDE","strength":"2.5MG\/1GM","dosageForm":"TABLET; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"05\/28\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/208454Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-05-28
)
)